The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Definitive thoracic radiotherapy in oligometastatic stage IV non-small cell lung cancer (NSCLC).
Annemarie Therese Fernandes
No relevant relationships to disclose
Eric Xanthopoulos
No relevant relationships to disclose
Elizabeth Handorf
No relevant relationships to disclose
Surbhi Grover
No relevant relationships to disclose
Sonam Sharma
No relevant relationships to disclose
Beth Eaby-Sandy
Consultant or Advisory Role - Amgen
Honoraria - Merck
Tracey L. Evans
No relevant relationships to disclose
James Stevenson
No relevant relationships to disclose
Corey J. Langer
No relevant relationships to disclose
Nandita Mitra
No relevant relationships to disclose
Smith Apisarnthanarax
No relevant relationships to disclose
Lilie Lin
No relevant relationships to disclose
Ramesh Rengan
No relevant relationships to disclose